Sign in

NCT07364981Not yet recruiting

Gaze Contingent Attentional Reinforcement in Major Depressive Disorder

Gaze Contingent Attentional Reinforcement Treatment of MDD

Source: ClinicalTrials.gov · Last updated 23 Jan 2026

Brief summary (registry, in English)

The main objective of this randomized controlled trial is to evaluate whether a gaze-contingent feedback task using negative reinforcement can serve as an effective attention-modification procedure and contribute to the treatment of Major Depressive Disorder (MDD).

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
29 Dec 2025
Start date
1 Jan 2026
Primary completion date
1 Jan 2030
Lead sponsor
Tel Aviv University
Diseases
Depression
NCT number
NCT07364981

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 1 Jan 2026 to the primary completion date, 1 Jan 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Pharmacological treatment if not stabilized for at least three months or concurrent psychotherapy

Other illness

  • Severe alcohol or cannabis use disorder, and/or any severity of other substance use disorder (exepct nicotine use)
  • Current unstable or untreated medical illness
  • Current or past organic mental disorder, seizure or brain injury

Other

  • Present or past psychosis, manic or hypomanic episode, PTSD
  • High suicidal ideation or behavior
  • Eye-tracking calibration difficulties
  • Post-ECT treatment

Who the study is looking for

  • Primary diagnosis of MDD
  • MADRS\>=7
  • Normal or corrected-t-normal vision

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tel Aviv University
Coordinator of this site? Confirm its status
Tel AvivIsraelUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.